Researcher | Founder AxialBridge | President Clinical Research Association of Canada
Canada
Joined January 2010
- Tweets2.9K
- Following1.8K
- Followers2.3K
- Likes6.5K
Don't miss our event "Big Data and RWE: The Canadian Opportunity" happening on Sept 25, 2024 during Life Sciences week in Calgary #bigdata #RWE #clinicaltrials #clinicalresearch
This is happening this evening! Still time to register. If you are conducting research learn how data & technology can assist with supporting effective clinical trials. we cover EDC, CTMS eTMF to how data & technology has impacted the CRA role. Dinner, Education, and Networking!
This Post is from an account that no longer exists. Learn more
Webinar on regulatory frameworks impacting psychedelic access:
-Francine Douglas, BA, is Stó:lō from Sts’ailes Nation and Tsimshian from Metlakatla Nation
-Madison Nobbs, RN & ED of KATA
-Valorie Masuda, MD, FCFP(EM)(PC) GPO, at RTT
-Shel Scott, Policy & Advocacy Lead MAPS Canada
MAPS Canada will host a webinar featuring experts in #psychedelictherapy as they share their insights on how emerging regulatory frameworks could impact access to these powerful drugs on Dec. 1st.
Places fill up fast, don't miss out: bit.ly/3Ec6ftI
My next event focusing on Future Considerations For Conducting Clinical Trials: Data & Technology is on Nov 17, 2022 in Toronto & Virtually. Discussions on EDC, eTMF and CTMS. Great evening of education, networking and a great meal. #data #clinicaltrials #EDC #CTMS #technology
This Post is from an account that no longer exists. Learn more
In the UK this month and Knowde Group is now in the UK and the newest members of the Canada-UK Chamber of Commerce and we have our official UK Launch event on Sept 29.
If you are free on Sept 14, 2022 @MAPSCanada has a screening of Better Living Through Chemistry @RevueCinema in Toronto. Followed by a Q&A with the director and an outstanding guest panel. See the link for more info. #psychedelics #psychotherapy #moviescreening
We invite you to attend the TO screening of Better Living Through Chemistry at @RevueCinema, on Sept. 14, 2022, followed by a Q&A. An excellent opportunity to learn about Ann & Sasha Shulgin's work and its impact on #psychedelics. We hope to see you there! eventbrite.ca/e/a-fundraiser…
Save the date Nov 17, 2022 we will discuss the Future of Clinical Trials: Data & Technology. #clinicaltrial #clinicalresearch #data #edc #technology #ai #BigData
Our next event on Sept 29, 2022 where we have a speaker discussing GCP Inspections and SOPs sites and sponsors required.
1/2 Canada on track to spend 200 Million on medical cannabis for veterans. More than 18,000 ex-millitary members were reimbursed from 2021 to 2022. globalnews-ca.cdn.ampproject…
The article mentions the need for clinical trials to assess benefits and harms. Some veterans & advocates argue that the rise in medical cannabis has helped to reduce use of opioids and other narcotics. #Veterans #cannabis #medicalcannabis
Sabrina Ramkellawan retweeted
We've added speakers to our upcoming #MarigoldLive PR & Branding in the Psychedelic Space virtual event.
Check them out and grab your free ticket while you're there.
bit.ly/3zlKd6o
@knowdegroup @SabrinaRamkell @SherryBoodram @CannDelta @KydderGroupInc @KatieEPringle
Next event Best Practices for a Successful GCP Inspection on September 29. In person and virtual event. #healthcanada #inspections #gcp @kimmcdt
@yycjpreezy craconline.ca/meeting/best-p…
Congrats on the first CIHR federally funded psilocybin trial @CAMHnews and @IshratHusain_
This Post is from an account that no longer exists. Learn more
Sabrina Ramkellawan retweeted
This week, we submitted an amendment to the National Defense Authorization Act that would require the Dep. of Defense to study the therapeutic benefits of psilocybin and MDMA — in addition to medicinal cannabis — for qualifying military service members.
Sabrina Ramkellawan retweeted
RIP Ann Shulgin 3.22.31–7.9.22. I had the pure joy of filming psychedelics legend Ann for How To Change Your Mind. It was her last interview but you’ll see she lights up the screen. “MDMA is penicillin for the soul. & you don’t give up on penicillin when you see what it can do”.
The first gene editing drug to help with blood disorders such as Sickle Cell may be FDA approved by 2023. fastcompany.com/90762983/gen…
Jazz cannabis spray for multiple sclerosis fails phase 3 trial seekingalpha.com/news/385236…
This slide covers the role of Health Canada's Clinical Trial Compliance Program. #healthcanada #clinicaltrialcomplianceprogram
